食物砂漠での生活が心房細動患者における血性脳卒中と入院リスクに与える影響
Eleanor Christianson1, Yingshuo Liu1, Alexander Dahl1
1Tulane Research Innovation for Arrhythmia Discovery, New Orleans, Louisiana, USA.
JACC. Advances
|August 29, 2025
まとめ
食物砂漠で生活すると 心房細動 (AF) の患者さんの脳卒中と死亡リスクが 大きく増加します この研究は 食物砂漠に住む AF患者の健康上の格差を強調しています
科学分野:
- 心血管の健康
- 公衆衛生
- 健康 の 格差
背景:
- 食事習慣は心臓血管の健康に大きな影響を与えます
- 心房細動 (AF) 患者に対する食物砂漠の特定の影響は十分に理解されていません.
- 食料砂漠とは 低価格で栄養価の高い食料が 限られている地域です
研究 の 目的:
- 食物砂漠での生活と AF患者の健康への悪影響との関連を調査する.
- 食物砂漠で生活するAF患者の 血栓性脳卒中,入院,死亡のリスクを評価する.
- AF患者集団における食物へのアクセスに関する潜在的な健康格差を特定する.
主な方法:
- 患者のデータのためにResearch Action for Health NetworkのデータベースとUSDAの食品アクセス研究アトラスを利用しました.
- AF患者は"内部の食物砂漠" (AFID) と"外部の食物砂漠" (AFOD) に分類しました.
- カプラン・マイヤー曲線と多変量コックスモデルを使用して,主要な人口統計的および臨床的要因を調整して結果を分析した.
主要な成果:
- AFID群 (1,115人) は,AFOD群 (438人) に比べて,著しく高いリスクを示した.
- 調整されたコックス回帰では,AFIDグループでは,不全性脳卒中のリスクが2. 21倍 (P=0. 02) 増加していた.
- AFIDグループでは,全因死亡のリスクが3. 84倍 (P=0. 01) であり,複合的なアウトカムのリスクが1. 42倍 (P< 0. 001) であった.
結論:
- 食物砂漠での居住は,AF患者における有害な結果の重要なリスク要因です.
- 食物砂漠に住む AF患者には 脳卒中と死亡リスクが かなり高まります
- 発見は,心臓血管疾患の管理のための公衆衛生の介入として,食料へのアクセスを扱う必要性を強調しています.
関連する概念動画
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27